Anders Jack sold 3,499 shares of Revolution Medicines, Inc. at $181.04 for −$633k on Nov 11, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Chief Financial Officer
Chief Financial Officer
Filed Nov 13, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$633,466.31Shares × reported price
Shares traded
3,499Common Stock
Price per share
$181.04Reported price. Read footnotes for ranges.
% of reported position traded
2.26%This security and ownership context
Holdings after
151,467Direct
Trade date
Nov 11, 2026Sell
Filed
Nov 13, 2026, 6:00 PM ET2-day reporting delay
Accession
0001193125-26-461145Code S · Transaction 401217
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 154,966 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Related trades are temporarily unavailable. Open the SEC filing for the complete report, or reload this page.

RVMD price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
RVMD · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 20, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago +13%1w ago +16%1d ago +12%
Returns since7d30d90d180d1y

Footnotes in full

F1: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 12, 2026. F2: The transaction was executed in multiple trades at prices ranging from $180.50 to $181.45, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F3: The transaction was executed in multiple trades at prices ranging from $181.51 to $182.50, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F4: The transaction was executed in multiple trades at prices ranging from $182.56 to $183.51, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F5: The transaction was executed in multiple trades at prices ranging from $183.59 to $184.56, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F6: The transaction was executed in multiple trades at prices ranging from $184.59 to $185.40, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F7: The transaction was executed in multiple trades at prices ranging from $185.96 to $186.68, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F8: The transaction was executed in multiple trades at prices ranging from $186.99 to $187.62, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F9: The transaction was executed in multiple trades at prices ranging from $190.43 to $191.34, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F10: The transaction was executed in multiple trades at prices ranging from $191.44 to $192.43, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F11: The transaction was executed in multiple trades at prices ranging from $192.44 to $193.37, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F12: Includes 43,650 restricted stock units. F13: Fully vested.